Atypical Endometrial Hyperplasia Treatment with Progestogens and Gonadotropin-Releasing Hormone Analogues: Long-Term Follow-up
- 31 May 1999
- journal article
- clinical trial
- Published by Elsevier in Gynecologic Oncology
- Vol. 73 (2), 299-304
- https://doi.org/10.1006/gyno.1998.5322
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Progestin Treatment of Atypical Hyperplasia and Well-Differentiated Carcinoma of the Endometrium in Women Under Age 40Obstetrics & Gynecology, 1997
- Treatment of Endometrial Hyperplasias with Gonadotropin-Releasing Hormone Agonists: Pathological, Clinical, Morphometric, and DNA-Cytometric DataGynecologic Oncology, 1997
- Progestin alone as primary treatment of endometrial carcinoma in premenopausal womenCancer, 1997
- A randomized trial of adjuvant progestagen in early endometrial cancerCancer, 1989
- The biologic significance of cytologic atypia in progestogen-treated endometrial hyperplasiaAmerican Journal of Obstetrics and Gynecology, 1989
- The behavior of endometrial hyperplasia. A long-term study of “untreated” hyperplasia in 170 patientsCancer, 1985
- Use of a super active luteinizing hormone releasing hormone (LHRH) agonist in the treatment of menorrhagiaBJOG: An International Journal of Obstetrics and Gynaecology, 1984
- Effect of a Progestational Agent on Endometrial Hyperplasia and Endometrial CancerObstetrics & Gynecology, 1964
- Genesis of endometrial carcinoma.I. Study of Prior BiopsiesCancer, 1949
- Precursors of Corpus Carcinoma Estrogens and Adenomatous HyperplasiaAmerican Journal of Obstetrics and Gynecology, 1947